XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Mar. 31, 2020         4,387,140      
Balance at Mar. 31, 2020 $ 0 $ (9) $ 0 $ (9) $ 158,023 $ 72,359 $ (10,369) [1] $ 220,013
Proceeds from issuance of common stock, net of issuance costs (in shares)         690,000      
Proceeds from issuance of common stock, net of issuance costs         $ 145,935 0 0 145,935
Exercise of stock options and vesting of restricted stock units (in shares)         65,532      
Exercise of stock options and vesting of restricted stock units         $ 4,943     4,943
Tax withholding on restricted stock units (in shares)         (2,104)      
Tax withholding on restricted stock units         $ (517) 0 0 (517)
Dividends paid           (3,165)   (3,165)
Stock-based compensation expense         9,268     9,268
Foreign currency translation             26,485 [1] 26,485
Net income         $ 0 3,274 0 3,274
Balance (in shares) at Mar. 31, 2021         5,140,568      
Balance at Mar. 31, 2021 $ (22,735) $ 5,684 $ 0 $ (17,051) $ 317,652 72,459 16,116 [1] 406,227
Exercise of stock options and vesting of restricted stock units (in shares)         128,337      
Exercise of stock options and vesting of restricted stock units         $ 8,027     8,027
Tax withholding on restricted stock units (in shares)         (3,278)      
Tax withholding on restricted stock units         $ (875) 0 0 (875)
Dividends paid           (3,339)   (3,339)
Stock-based compensation expense         11,391     11,391
Foreign currency translation             (12,450) (12,450)
Net income         $ 0 1,871 0 $ 1,871
Balance (in shares) at Mar. 31, 2022         5,265,627     5,265,627
Balance at Mar. 31, 2022         $ 313,460 76,675 3,666 [1] $ 393,801
Exercise of stock options and vesting of restricted stock units (in shares)         108,737     73,000
Exercise of stock options and vesting of restricted stock units         $ 6,997 0 0 $ 6,997
Tax withholding on restricted stock units (in shares)         (4,898)      
Tax withholding on restricted stock units         $ (919) 0 0 (919)
Dividends paid         0 (3,406) 0 (3,406)
Stock-based compensation expense         12,538 0 0 12,538
Foreign currency translation         $ 0 0 (16,461) (16,461)
Net income           930   $ 930
Balance (in shares) at Mar. 31, 2023         5,369,466     5,369,466
Balance at Mar. 31, 2023         $ 332,076 $ 74,199 $ (12,795) [1] $ 393,480
[1] Accumulated Other Comprehensive Income (Loss).